Rep. Pallone’s Energy And Commerce Win Is Salve For Generics
This article was originally published in The Pink Sheet Daily
Anna Eshoo, who championed the brand-friendly biosimilars pathway, had challenged Pallone for ranking member post in House Energy and Commerce Committee.
You may also be interested in...
Retiring after 40 years in Congress, Waxman leaves an enormous legacy, but also many recent legislative defeats.
Lopsided committee vote suggests that lengthy exclusivity is here to stay, which means that big pharma can get more comfortably behind the broader reform effort.
Pink Sheet Podcast: Finally, A US FDA User Fee Deal, ‘Pandemic Is Over’ Take-Aways, Tpoxx Development Issues
Pink Sheet reporters and editor discuss the impact of the long wait for a user fee deal to be negotiated, how the FDA will interpret President Biden’s statement that the COVID-19 pandemic is over, and concerns with the clinical development of the monkeypox treatment Tpoxx.